These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2158911)

  • 41. Plasma concentration of alpha-hANP and renal responses to alpha-hANP infusion in patients with congestive heart failure and those with chronic renal failure.
    Hirata Y; Ishii M; Matsuoka H; Sugimoto T; Iizuka M; Serizawa T; Kohmoto O; Sugimoto T; Miyata A; Kangawa K
    Jpn Circ J; 1988 Dec; 52(12):1459-64. PubMed ID: 2853775
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Permissive action of glucocorticoid substitution therapy on the effects of atrial natriuretic peptide (hANP) in patients with adrenocortical insufficiency.
    Damjancic P; Vierhapper H
    Exp Clin Endocrinol; 1990 Aug; 95(3):315-21. PubMed ID: 2174002
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exaggerated natriuresis induced by sodium chloride infusion in essential hypertension is accompanied by an exaggerated urinary 3' 5' guanosine monophosphate excretion.
    Widecka K; Celibała R; Goździk J; Syrenicz A; Ciechanowski K; Czekalski S
    Nephrol Dial Transplant; 1993; 8(8):711-5. PubMed ID: 8414156
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High plasma concentrations of human atrial natriuretic polypeptide in aged men.
    Ohashi M; Fujio N; Nawata H; Kato K; Ibayashi H; Kangawa K; Matsuo H
    J Clin Endocrinol Metab; 1987 Jan; 64(1):81-5. PubMed ID: 3023430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prolonged administration of human atrial natriuretic peptide in healthy men: evanescent effects on diuresis and natriuresis.
    Waldhäusl W; Vierhapper H; Nowotny P
    J Clin Endocrinol Metab; 1986 May; 62(5):956-9. PubMed ID: 2937802
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Influence of plasma alpha-human atrial natriuretic polypeptide on natriuretic and diuretic effects in patients with nephrotic syndrome].
    Wang YX; Lin SY; Qiu CL
    Zhonghua Nei Ke Za Zhi; 1990 Oct; 29(10):589-92, 636. PubMed ID: 1964888
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma concentration and renal effect of human atrial natriuretic peptide in nephrotic syndrome.
    Hisanaga S; Yamamoto Y; Kida O; Kato J; Fujimoto S; Tanaka K
    Nihon Jinzo Gakkai Shi; 1989 Jun; 31(6):661-9. PubMed ID: 2529385
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Normal short-term renal response to acute volume expansion in heart transplant recipients: a role for atrial natriuretic peptide?
    Geny B; Charloux A; Schaefer A; Brandt C; Charpentier A; Kretz JG; Eisenmann B; Haberey P; Piquard F
    J Heart Lung Transplant; 1998 Nov; 17(11):1081-8. PubMed ID: 9855447
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prolonged decrease in blood pressure after atrial natriuretic peptide infusion in essential hypertension: a new anti-pressor mechanism?
    Singer DR; Markandu ND; Buckley MG; Miller MA; Sugden AL; Sagnella GA; MacGregor GA
    Clin Sci (Lond); 1989 Sep; 77(3):253-8. PubMed ID: 2530019
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of high dose atrial natriuretic peptide on renal haemodynamics, sodium handling and hormones in cirrhotic patients with and without ascites.
    Jespersen B; Eiskjaer H; Jensen JD; Mogensen CE; Sørensen SS; Pedersen EB
    Scand J Clin Lab Invest; 1995 Jul; 55(4):273-87. PubMed ID: 7569729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence for lack of a role of cGMP in effect of alpha-hANP on aldosterone inhibition.
    Matsuoka H; Ishii M; Hirata Y; Atarashi K; Sugimoto T; Kangawa K; Matsuo H
    Am J Physiol; 1987 May; 252(5 Pt 1):E643-7. PubMed ID: 3034071
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kinetics of plasma cyclic GMP and atrial natriuretic peptide after intravenous, intramuscular and subcutaneous injection of 50 micrograms hANP in man.
    Osterode W; Nowotny P; Vierhapper H; Waldhäusl W
    Horm Metab Res; 1995 Feb; 27(2):100-3. PubMed ID: 7759055
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Atrial natriuretic peptide--cyclic GMP coupling and urinary sodium excretion during acute volume expansion in man.
    Sagnella GA; Singer DR; Markandu ND; MacGregor GA; Shirley DG; Tremblay J; Hamet P
    Can J Physiol Pharmacol; 1990 Apr; 68(4):535-8. PubMed ID: 2158388
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dose-response study of atrial natriuretic peptide bolus injection in healthy man.
    Eiskjaer H; Pedersen EB
    Eur J Clin Invest; 1993 Jan; 23(1):37-45. PubMed ID: 8383057
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cosecretion of peptides derived from gamma-human atrial natriuretic polypeptide in normal volunteers and patients with essential hypertension and adrenal disorders.
    Sugawara A; Nakao K; Itoh H; Yamada T; Saito Y; Mukoyama M; Arai H; Hosoda K; Shirakami G; Morii N
    J Hypertens Suppl; 1988 Dec; 6(4):S327-9. PubMed ID: 2977172
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of intraoperative hypertension with enflurane, nicardipine, or human atrial natriuretic peptide: haemodynamic and renal effects.
    Goto F; Kato S; Sudo I
    Can J Anaesth; 1992 Nov; 39(9):932-7. PubMed ID: 1451221
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protective effect of alpha-human atrial natriuretic polypeptide (alpha-hANP) on chemical-induced pulmonary edema.
    Imamura T; Ohnuma N; Iwasa F; Furuya M; Hayashi Y; Inomata N; Ishihara T; Noguchi T
    Life Sci; 1988; 42(4):403-14. PubMed ID: 2828791
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Atrial natriuretic peptide in patients with essential hypertension. Hemodynamic, renal, and hormonal responses.
    Predel HG; Schulte-Vels O; Glänzer K; Meyer-Lehnert H; Kramer HJ
    Am J Hypertens; 1991 Nov; 4(11):871-9. PubMed ID: 1665067
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel atrial natriuretic peptide based therapeutic in experimental angiotensin II mediated acute hypertension.
    McKie PM; Cataliotti A; Boerrigter G; Chen HH; Sangaralingham SJ; Martin FL; Ichiki T; Burnett JC
    Hypertension; 2010 Dec; 56(6):1152-9. PubMed ID: 20975033
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of human atrial natriuretic peptide on renal function and vasopressin release.
    Kimura T; Abe K; Shoji M; Tsunoda K; Matsui K; Ota K; Inoue M; Yasujima M; Yoshinaga K
    Am J Physiol; 1986 May; 250(5 Pt 2):R789-94. PubMed ID: 2939732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.